granted
on 04 Jan 2024
Last Applicant/ Owned by
150 CambridgePark Drive, 9th Floor
Cambridge
MA
02140
Serial Number
97491217 filed on 06th Jul 2022
Registration Number
N/A
Correspondent Address
John V. Hobgood, Esquire
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Scientific research; Pharmaceutical research; Medical research; Engineering of biological cells; genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering EN FUEL Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; Read More
Scientific research; Pharmaceutical research; Medical research; Engineering of biological cells; genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering
Custom manufacture of pharmaceuticals for others; Custom manufacturing of biological cells; consultation in the field of custom manufacture of pharmaceuticals and biological cells
Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders
No 97491217
No Service Mark
No 2217678.121
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
06th Jan 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
04th Jan 2024 | SOU TEAS EXTENSION RECEIVED |
04th Jan 2024 | SOU EXTENSION 1 FILED |
04th Jan 2024 | SOU EXTENSION 1 GRANTED |
04th Jul 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
09th May 2023 | PUBLISHED FOR OPPOSITION |
09th May 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
19th Apr 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
03rd Apr 2023 | EXAMINERS AMENDMENT -WRITTEN |
03rd Apr 2023 | EXAMINERS AMENDMENT E-MAILED |